197 related articles for article (PubMed ID: 9669118)
1. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone: evaluation of 68 cases.
Pericin M; Trüeb RM
Dermatology; 1998; 196(4):418-21. PubMed ID: 9669118
[TBL] [Abstract][Full Text] [Related]
2. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
Aghaei S
BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
[TBL] [Abstract][Full Text] [Related]
3. Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata--a large retrospective study on 142 patients with a self-controlled design.
Ohlmeier MC; Traupe H; Luger TA; Böhm M
J Eur Acad Dermatol Venereol; 2012 Apr; 26(4):503-7. PubMed ID: 21569118
[TBL] [Abstract][Full Text] [Related]
4. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
Galadari I; Rubaie S; Alkaabi J; Galadari H
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
Durdu M; Özcan D; Baba M; Seçkin D
J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
[TBL] [Abstract][Full Text] [Related]
6. Retrospective review of diphencyprone in the treatment of alopecia areata.
Lamb RC; Young D; Holmes S
Clin Exp Dermatol; 2016 Jun; 41(4):352-8. PubMed ID: 26620737
[TBL] [Abstract][Full Text] [Related]
7. Erythema multiforme-like eruptions: a rare side effect of topical immunotherapy with diphenylcyclopropenone.
Perret CM; Steijlen PM; Zaun H; Happle R
Dermatologica; 1990; 180(1):5-7. PubMed ID: 2137800
[TBL] [Abstract][Full Text] [Related]
8. Topical immunomodulation with diphenylcyclopropenone for alopecia areata: the Lebanese experience.
El Khoury J; Abd-el-Baki J; Succariah F; Abbas O; Kibbi AG; Kurban M
Int J Dermatol; 2013 Dec; 52(12):1551-6. PubMed ID: 24134785
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
[TBL] [Abstract][Full Text] [Related]
10. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
Chiang KS; Mesinkovska NA; Piliang MP; Bergfeld WF
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):50-5. PubMed ID: 26551948
[TBL] [Abstract][Full Text] [Related]
11. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
[TBL] [Abstract][Full Text] [Related]
12. Treatment of alopecia areata with diphenylcyclopropenone.
van der Steen PH; van Baar HM; Perret CM; Happle R
J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):253-7. PubMed ID: 2007671
[TBL] [Abstract][Full Text] [Related]
13. Five-year experience in the treatment of alopecia areata with DPC.
El-Zawahry BM; Bassiouny DA; Khella A; Zaki NS
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):264-9. PubMed ID: 19744175
[TBL] [Abstract][Full Text] [Related]
14. Possible advantage of imiquimod and diphenylcyclopropenone combined treatment versus diphenylcyclopropenone alone: An observational study of nonresponder patients with alopecia areata.
Wasyłyszyn T; Borowska K
Australas J Dermatol; 2017 Aug; 58(3):219-223. PubMed ID: 27087586
[TBL] [Abstract][Full Text] [Related]
15. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
[TBL] [Abstract][Full Text] [Related]
16. Alopecia areata: topical immunotherapy treatment with diphencyprone.
Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of alopecia areata with diphenylcyclopropenone].
Kietzmann H; Hardung H; Christophers E
Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of alopecia areata with diphenylcyclopropenone].
Ochsendorf FR; Mitrou G; Milbradt R
Z Hautkr; 1988 Feb; 63(2):94, 96, 99-100. PubMed ID: 3376515
[TBL] [Abstract][Full Text] [Related]
19. Topical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significance.
Weise K; Kretzschmar L; John SM; Hamm H
Dermatology; 1996; 192(2):129-33. PubMed ID: 8829494
[TBL] [Abstract][Full Text] [Related]
20. Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.
Tobin DJ; Gardner SH; Lindsey NJ; Hoffmann R; Happle R; Freyschmidt-Paul P
Eur J Dermatol; 2002; 12(4):327-34. PubMed ID: 12095876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]